We propose cut-offs for definite active and structural lesions typical of axSpA that have high PPVs for a long-term clinical diagnosis of axSpA for application in disease classification and clinical research.
No takes yet. Share an insight, caveat, or question.
Maksymowych et al. (2021) studied this question.